insights_auto
Parashikimi: 33.3% optimist·2.8% pesimist
Shko tek analizachevron_right
AMGN:NASDAQ
Amgen Inc
424,94 US$
arrow_downward
-1,75%(-7,55) 1D
424,94 US$
0,00% (0,00)
bedtimeJashtë orarit
Mbyllur: 19 tet, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN...
Hap
430,36 US$
I lartë
434,51 US$
I ulët
424,74 US$
Kapitalizimi i tregut
229,74 mld
Vëllimi mesatar
3,11 mln
Vëllimi
2,68 mln
Dividendi
2,37%
Dividendi tremujor
2,52 US$
Data e ndërprerjes së dividendit
21 gush 2026
Raporti çmim/fitim
26,39
Maksimumi 52-javor
447,03 US$
Minimumi 52-javor
288,00 US$
Fitimet për aksion
16,10 US$
Beta
0,41
Aksionet në qarkullim
540,63 mln
Numri i punonjësve
32 mijë
Hap
430,36 US$
I lartë
434,51 US$
I ulët
424,74 US$
Kapitalizimi i tregut
229,74 mld
Vëllimi mesatar
3,11 mln
Vëllimi
2,68 mln
Dividendi
2,37%
Dividendi tremujor
2,52 US$
Data e ndërprerjes së dividendit
21 gush 2026
Raporti çmim/fitim
26,39
Maksimumi 52-javor
447,03 US$
Minimumi 52-javor
288,00 US$
Fitimet për aksion
16,10 US$
Beta
0,41
Aksionet në qarkullim
540,63 mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
MarketBeat
·
2 orë më parë
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group
Yahoo Finance
·
4 orë më parë
Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?
Securities.io
·
10 orë më parë
Amgen (AMGN): The Biotech Pioneer Preparing for Its Next Growth Wave
ad-hoc-news.de
·
12 orë më parë
Amgen stock: At EUR 383.40, Amgen stock has a USD 233.7 billion market value
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiamgen.com